在白发症区域中,AhR通路的调节失调
Arno Belpaire1,2, Annelies Demeyer2, Elise Van Caelenberg1,2
1Department of Dermatology, Ghent University Hospital, Corneel Heymanslaan 10, 9000, Ghent, Belgium.
Journal of translational autoimmunity
|March 31, 2025
概括
阿里碳水化合物受体 (AhR) 途径在白发性脱发症 (AA) 患者中显著下调,这表明它可能是这种与免疫相关的脱发条件的治疗标.
科学领域:
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
- 分子生物学分子生物学
背景情况:
- 脱毛区 (AA) 发病过程涉及复杂的免疫信号,其中干扰素- (IFN-γ) 起着中心作用,导致治疗耐药性.
- 基碳化合物受体 (AhR) 途径在调节T-辅助体17 (Th17) 反应中的作用及其与AA中IFN-γ的相互作用仍然不清楚.
- 虽然在AA中IL-17水平升高,但IL-17A抑制剂的有效性有限,AhR在免疫检查点诱导中的潜在作用需要调查.
研究的目的:
- 为了研究白区 (AA) 患者的淋巴细胞中aryl碳化合物受体 (AhR) 的表达.
- 评估AhR表达与AA疾病活动的临床/实验室标志物之间的关联.
- 探索针对AA中的AhR途径的诊断实用性和治疗潜力.
主要方法:
- 从AA患者和健康对照中量化CD4+,CD8+,Th1和Th17淋巴细胞中的AhR表达.
- 对AhR水平与脱发症严重程度工具 (SALT) 评分和IFN-γ/IL-17+淋巴细胞计数的相关性分析.
- 接收器操作特征 (ROC) 分析,以评估CD8+细胞中AhR水平的诊断潜力.
- 对免疫检查点 (ICP) 表达的分析,包括可溶性PD-1 (sPD-1),与亚热和非亚热AA亚组中的AhR水平相关.
主要成果:
- 与对照人群相比,AA患者的CD4+,CD8+,Th1和Th17淋巴细胞的AhR表达显著降低 (p < 0.005).
- 较低的AhR水平与SALT得分 (p <0.05),IFN-γ+淋巴细胞的增加和IL-17+免疫细胞的减少相反相关.
- CD8+细胞中的AhR水平显示出高灵敏度 (82.35%) 和特异性 (86.84%) 在区分轻度AA与健康对照中.
- 在严重的AA中,更高的AhR与增加的sPD-1相关,而在有限的AA中,AhR没有上调研究的ICPs.
结论:
- 阿里碳水化合物受体 (AhR) 途径在白发性 (AA) 淋巴细胞中显著下调.
- 减少AhR表达与AA中增加的疾病活性和特定免疫特征有关.
- 降低AhR的调节表明它有可能成为AA的诊断标记物和治疗点,可能是通过激动剂或对抗剂.
相关概念视频
Hedgehog Signaling Pathway
7.3K
The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.3K
The JAK-STAT Signaling Pathway
8.5K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.5K
Role Of Notch Signalling In Intestinal Stem Cell Renewal
2.0K
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.0K
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K


